How RNA acetylation links liver disease and antitumor immunity (IMAGE)
Caption
The NAT10/ac4C system can support fat accumulation in hepatocytes, scar formation by hepatic stellate cells, and growth or treatment resistance in liver cancer cells. Its effects depend on the RNA target, cell type and disease stage. Reduced ac4C in certain myeloid immune cells may weaken antitumor immunity, highlighting the need to investigate treatments that target disease-promoting cells while preserving protective immune functions. The schematic summarizes the review's proposed framework rather than a clinically validated treatment.
Credit
©Ying-li Zhu and Xiao-long Zhou / Medicine Plus. Reproduced from Figure 1 of the review
Usage Restrictions
use with credit.
License
Original content